Matthew D. Landrigan,Krista OShaughnessey,Jennifer E. Woodell-May,David L. Suter
申请号：
US13841103
公开号：
US09895418B2
申请日:
2013.03.15
申请国别(地区):
US
年份:
2018
代理人:
摘要：
Methods of treating peripheral vascular disease comprising administering a protein solution site of a defect at least two proteins from the group IL-1ra, sTNF-RI, sTNF-RII, IGF-I, EGF, HGF, PDGF-AB, PDGF-BB, VEGF, TGF-β1, and sIL-1RII. The solution may also comprise white blood cells, platelets, concentrated bone marrow aspirate, and combinations thereof.
